Pentagon requests $18B in emergency funding for missile stocks, and the macro ripple effects are hard to ignore
Increased defense spending could elevate bond yields, strengthen the dollar, and influence broader economic and crypto market dynamics. The post Pentagon requests $18B in emergency funding for missile stocks, and the mac...
Watchlist
Published in the last two hours. A tracked entity is involved.
Increased defense spending could elevate bond yields, strengthen the dollar, and influence broader economic and crypto market dynamics.
The post Pentagon requests $18B in emergency funding for missile stocks, and the macro ripple effects are hard to ignore appeared first on Crypto Briefing.
Why this matters
XRP is showing up inside the Macro & Rates theme, so this story is worth tracking for follow-through rather than treating it as a one-off headline.
Original source
Read on Crypto BriefingRelated market context
Ripple Just Got Full MiCA Authorization in Europe But Fed’s Hawkish Tone Is Keeping XRP Capped at $1.10
In the latest XRP News, XRP price is trading at $1.07, down 0.57% in the last 24 hours, as the asset continues to wrestle with the...
Crypto News, July 31: July Round Up, Kospi Coming Back, Bitcoin Price Ignores Political Noise as Market Splits
The Kospi ended July with a powerful rebound, while the Bitcoin price stayed remarkably steady despite several major headlines. We...
Bitcoin price sinks to 2-week lows as US stocks diverge from Asia
Bitcoin's decline amid diverging global markets highlights its vulnerability to macroeconomic shifts and tech sector volatility, i...
Korean stocks are now more volatile than Bitcoin, and US bonds aren’t far behind
Increased volatility in Korean stocks highlights the risks of concentrated market dependencies, potentially impacting global inves...
Bitcoin hashrate decline nears 287 days as miner stocks surge
The shift from Bitcoin mining to AI hosting highlights a strategic pivot, potentially stabilizing revenue but increasing market co...
Biotech company asks shareholders to dilute stock by 951% to hoard illiquid crypto token instead of funding its own drug
Enlivex, a Nasdaq-listed biotechnology company, is asking shareholders to authorize up to $800 million of financing tied to the RA...